immunologic technique
immunologic technique is an intervention with 65 clinical trials. Historical success rate of 91.4%.
Success Metrics
Based on 53 completed trials
Phase Distribution
Phase Distribution
18
Early Stage
15
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
89.8%
53 of 59 finished
10.2%
6 ended early
0
trials recruiting
65
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
Clinical Trials (65)
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 65